The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and the resulting Coronavirus disease 2019 emerged in late 2019 and is responsible for significant morbidity and mortality worldwide. A hallmark of severe COVID‐19 is exaggerated systemic inflammation, regarded as a “cyt...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Kiran Deshpande, Keith R. Lange, William B. Stone, Christine Yohn, Naomi Schlesinger, Leonid Kagan, Albert J. Auguste, Bonnie L. Firestein, Luigi Brunetti
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2023-06-01
Schriftenreihe:	Pharmacology Research & Perspectives
Schlagworte:	COVID‐19 drug transporters drug‐metabolizing enzymes hACE2 SARS‐CoV‐2
Online-Zugang:	https://doi.org/10.1002/prp2.1071
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!